# Estrella Immunopharma, Inc.: Form 8-K, filed Aug 7, 2025

- Company: [Estrella Immunopharma, Inc.](/companies/esla.md) (CIK 1844417)
- Form: 8-K
- Filed: 2025-08-07
- Accepted by EDGAR: Aug 6, 2025, 20:32 ET
- Period: 2025-08-01
- Accession: 0001213900-25-072746
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1844417/000121390025072746/ea0252082-8k_estrella.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1844417/000121390025072746/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1844417/000121390025072746/ea0252082-8k_estrella.htm

Filed Aug 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-072746. Last ingested by Listed: Nov 4, 2026, 07:37 ET. No prices; not investment advice.